KNSA (Kiniksa Pharmaceuticals International) Float Percentage Of Total Shares Outstanding: 49.39% (As of Jul. 01, 2026)


KNSA Kiniksa Pharmaceuticals International PLC KNSA
54 GF Score
Price $62.88
GF Value $48.12
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Kiniksa Pharmaceuticals International Float Percentage Of Total Shares Outstanding?

Kiniksa Pharmaceuticals International KNSA -1.57% 54 Float Percentage Of Total Shares Outstanding is 49.39% as of Jul. 01, 2026. GuruFocus rates KNSA with a GF Score™ of 54/100 and a GF Value™ of $48.12 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Kiniksa Pharmaceuticals International's float shares is 38.00 Mil. Kiniksa Pharmaceuticals International's total shares outstanding is 76.94 Mil. Kiniksa Pharmaceuticals International's float percentage of total shares outstanding is 49.39%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Kiniksa Pharmaceuticals International's Insider Ownership is 0.95%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Kiniksa Pharmaceuticals International's Institutional Ownership is 63.08%.

KNSA
54GF Score
Kiniksa Pharmaceuticals International PLC KNSA
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kiniksa Pharmaceuticals International Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Kiniksa Pharmaceuticals International's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=38.00/76.94
=49.39%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 49.39% mean?
Kiniksa Pharmaceuticals International (KNSA) has a Float Percentage Of Total Shares Outstanding of 49.39% as of Jul. 01, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Kiniksa Pharmaceuticals International and its competitors.
Is Kiniksa Pharmaceuticals International's Float Percentage Of Total Shares Outstanding too high?
Kiniksa Pharmaceuticals International's current Float Percentage Of Total Shares Outstanding is 49.39%. Overall, Kiniksa Pharmaceuticals International has a GF Score™ of 54/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Kiniksa Pharmaceuticals International's Float Percentage Of Total Shares Outstanding compare to INDV and AMRX?
Kiniksa Pharmaceuticals International's Float Percentage Of Total Shares Outstanding of 49.39% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Drug Manufacturers company?
A good Float Percentage Of Total Shares Outstanding depends on the Drug Manufacturers industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Kiniksa Pharmaceuticals International and its competitors. Kiniksa Pharmaceuticals International's current Float Percentage Of Total Shares Outstanding is 49.39%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kiniksa Pharmaceuticals International stock overvalued right now?
Based on GuruFocus' analysis, Kiniksa Pharmaceuticals International (KNSA) is currently considered Significantly Overvalued. The stock's GF Value™ is $48.12, compared to a current price of $62.88 — trading 30.7% above its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 49.39%. Kiniksa Pharmaceuticals International's overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Kiniksa Pharmaceuticals International (KNSA), the current Float Percentage Of Total Shares Outstanding is 49.39% as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kiniksa Pharmaceuticals International (KNSA) Overvalued in 2026?

Based on GuruFocus' analysis, Kiniksa Pharmaceuticals International stock appears to be overvalued. The current stock price of $62.88 is trading 30.7% above its estimated GF Value™ of $48.12. GuruFocus considers Kiniksa Pharmaceuticals International to be Significantly Overvalued.

Key valuation signals for KNSA:

  • Float Percentage Of Total Shares Outstanding: 49.39%
  • GF Value™: $48.12 vs. price of $62.88 (30.7% above fair value)
  • GF Score™: 54/100 with 4 warning signs

No single metric tells the full story. See the KNSA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kiniksa Pharmaceuticals International Business Description

Address 105 Piccadilly, Second Floor, London, GBR, W1J 7NJ
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
54GF Score

Get the complete analysis for KNSA

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$62.88
Price
$48.12
GF Value